We are live on
!
Find out more
PTA
Pear Tree Advisors Portfolio holdings
AUM
$238M
1-Year Est. Return
3.59%
This Fund
S&P 500
This Quarter
Est. Return
-9.81%
1 Year Est. Return
+3.59%
3 Year Est. Return
+45.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.8M
AUM Growth
–
Cap. Flow
+$78.4M
Cap. Flow
% of AUM
104.8%
Top 10 Holdings %
Top 10 Hldgs %
94.87%
Holding
39
New
39
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$21.2M |
| 2 |
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
|
+$21.1M |
| 3 |
Infosys
INFY
|
+$19.8M |
| 4 |
Methanex
MEOH
|
+$7.22M |
| 5 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$1.38M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.54% |
| 2 | Technology | 25.04% |
| 3 | Materials | 10.63% |
| 4 | Consumer Staples | 2.8% |
| 5 | Energy | 2.28% |
Similar funds
DAM
MRM
3I
ACMM
AAM
IMAS
RDM
VP
Pear Tree Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Pear Tree Advisors, which disclosed 39 positions worth $74.8M. Its ten largest holdings account for 95% of the portfolio.
Its largest position is Teva Pharmaceuticals: 544,919 shares worth $21.4M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, followed by Technology and Materials.
- Pear Tree Advisors's largest Q2 2013 buy was Teva Pharmaceuticals: 544,919 shares worth $21.4M.
- Pear Tree Advisors's ten largest holdings make up 95% of its $74.8M portfolio in Q2 2013.
- Pear Tree Advisors disclosed 39 positions in Q2 2013, its first 13F filing on record.
Based on Pear Tree Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.